IP Library Granted Patent US 12,564,566
Granted Patent B2
US 12,564,566 · App. 17/633,340 · Granted Mar 3, 2026

Uses of long-chain polyunsaturated fatty acids

Inventors: Andrew Pipingas (Mount Waverley, AU); Andrew Scholey (Clifton Hill, AU)
Assignee: Swinburne University of Technology
A61K31/202A61K9/0053A61K9/0095A61K35/60A61P9/02A61P9/12A61P25/28
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,564,566
App. No.
17/633,340
Granted
Mar 3, 2026
Kind
B2
Abstract

The present invention is directed to methods of acutely improving or enhancing cardiovascular and/or cognitive function, comprising the administration of LCPUFAs, in particular docosahexanoic acid (DHA), uses and compositions thereof.

Claims (11)

1 . A method for acutely reducing blood pressure or pulse pressure in a subject, the method comprising administering to the subject docosahexaenoic acid (DHA).

2 . The method of claim 1 , wherein the DHA is present in triglyceride form, ethyl ester form, phospholipid form, or free fatty acid form.

3 . The method of claim 1 , wherein the DHA is LCPUFAs are present in one or more DHA-containing oils.

4 . The method of claim 3 , wherein the one or more DHA-containing oils comprise an oil obtained from a single cell organism, a plant oil or a fish oil, or a concentrated form thereof.

5 . The method of claim 1 , wherein the DHA is administered in a dose of at least about 500 mg.

6 . The method of claim 5 , wherein the DHA is administered in a dose of about 4 g.

7 . The method of claim 1 , wherein the reduction in blood pressure or pulse pressure in the subject occurs within about 4 hours of administration of the DHA.

8 . The method of claim 1 , wherein the DHA is administered orally.

9 . The method of claim 8 , wherein the DHA is added to a food or drink for consumption by the subject prior to administration.

10 . The method of claim 1 , wherein the reduction in blood pressure comprises a reduction in brachial systolic blood pressure and/or in aortic systolic blood pressure, a reduction in brachial and/or aortic diastolic blood pressure, and/or a reduction in brachial and/or aortic mean arterial blood pressure.

11 . The method of claim 1 , wherein the reduction in pulse pressure comprises a reduction in brachial pulse pressure and/or a reduction in aortic pulse pressure.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2022
From: PIPINGAS, ANDREW; SCHOLEY, ANDREW
To: SWINBURNE UNIVERSITY OF TECHNOLOGY
Reel/Frame 059301/0449 →
Priority Claims (1)
AU 2019902840 · Aug 8, 2019 · national
Continuity (1)
Related Publication 20220280465A1 · Sep 8, 2022
References Cited (17)
US 20180044278A1 · Bazan · 2018 [cited by examiner]
EP 1800675B1 · 2011 [cited by applicant]
RU 2014141406A · 2016 [cited by applicant]
WO 2010088700A1 · 2010 [cited by applicant]
Elsen et al. Current Pharmaceutical Design, 2012, 18(16): 2375-2392. [cited by examiner]
Mcmanus, S , et al., “Differential effects of EPA versus DHA on postprandial vascular function and the plasma oxylipin profile in men”, J. Lipid Res 57, 1720-1727 (2016). [cited by applicant]
Chino, D , et al., “Acute Effects of Intravenous Administration of Polyunsaturated Fatty Acids on Blood Pressure and Heart Rate in U46619- and Noradrenaline-infused Rats”, British Journal of Pharmaceutical Research 15(3… [cited by applicant]
Mcnamara, R , et al., “Cognitive Response to Fish Oil, Blueberry, and Combined Supplementation in Older Adults with Subjective Cognitive Impairment”, Neurobiol Aging 64, 147-156 (2018). [cited by applicant]
Morgese, M , et al., “Chlorella sorokiniana Extract Improves Short-Term Memory in Rats”, Molecules 21, 1311, doi:10.3390/molecules21101311, 1-17 (2016). [cited by applicant]
Nilsson, A , et al., “Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over … [cited by applicant]
Pase, M , et al., “The Effects of Long-Chain Omega-3 Fish Oils and Multivitamins on Cognitive and Cardiovascular Function: A Randomized, Controlled Clinical Trial”, Journal of the American College of Nutrition 34 (1), 2… [cited by applicant]
Patent Cooperation Treaty , International Search Report and Written Opinion for PCT/AU2020/050822, 14 pages, dated Oct. 6, 2020. [cited by applicant]
Rontoyanni, V , et al., “A comparison of the changes in cardiac output and systemic vascular resistance during exercise following high-fat meals containing DHA or EPA”, British Journal of Nutrition 108, 492-499 (2012). [cited by applicant]
Witte, A , et al., “Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults”, Cerebral Cortex 24, 3059-3068 (2014). [cited by applicant]
Chinese Office Action, for CN Application No. 202080068283.7, 6 pages, dated Dec. 16, 2024. [including English Translation]. [cited by applicant]
Li Guangzhi, “Coronary Heart Disease”, China Pharmaceutical Science and Technology Press, p. 41 (2009). [cited by applicant]
Wang Hongxin, et al., “New Food Resource”, China Light Industry Press, p. 273 (2002). [cited by applicant]